Company Filing History:
1 out of 832,812 Years Active: 2002
Title: Innovations in Dengue Virus Research: The Contributions of Rosmari Rodriguez Roche
Introduction
Rosmari Rodriguez Roche is a dedicated inventor based in Habana, Cuba, who has made significant contributions to the field of virology through his innovative research on the dengue virus. His work primarily focuses on the development of synthetic peptides and chimeric proteins, which have important implications for vaccine development and immune response.
Latest Patents
Rosmari holds a notable patent titled "Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use." This invention relates to the identification of five synthetic peptides of the pre-M/M protein of the Dengue-2 virus, which are based on specific amino acid sequences. The peptides evaluated have shown a strong potential for eliciting an immune response, highlighting their role in generating neutralizing antibodies against the dengue virus. His research has culminated in significant findings, such as proving the efficacy of certain peptides in protecting against the Dengue-2 virus in mice.
Career Highlights
Throughout his career, Rosmari Rodriguez Roche has focused on the intersection of molecular biology and immunology. His inventive approaches have contributed to a deeper understanding of the dengue virus and its mechanisms, which are crucial for advancing therapeutic strategies. By demonstrating the presence of B cell epitopes in his synthetic peptides, he has opened new avenues for future research and vaccine development.
Collaborations
Rosmari has collaborated with esteemed coworkers, including Susana Vazquez Ramudo and Guadalupe Guzman Tirado. These collaborations reflect a team-oriented approach to science, allowing for the merging of diverse expertise and insights that enrich the research findings and enhance the scope of innovation in their projects.
Conclusion
In summary, Rosmari Rodriguez Roche stands out as an inventive force in the battle against dengue virus through the exploration of synthetic peptides. His patented work not only advances scientific understanding but also holds promise for practical applications in vaccine formulations. As his research continues, the impact of his contributions will likely resonate within the fields of virology and immunology for years to come.